Literature DB >> 31311694

Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017.

Changseung Liu1, Eun-Jeong Yoon1, Dokyun Kim1, Jong Hee Shin2, Jeong Hwan Shin3, Kyeong Seob Shin4, Young Ah Kim5, Young Uh6, Hyun Soo Kim7, Young Ree Kim8, Seok Hoon Jeong9.   

Abstract

At the end of 2015, a global action plan on antimicrobial resistance (AMR) was proposed by the World Health Organization, and the Global AMR Surveillance System (GLASS) was subsequently initiated. The Centers for Disease Control and Prevention of South Korea established a customized AMR surveillance system for South Korea, called Kor-GLASS, in early 2016. A pilot phase of Kor-GLASS was operated from May to December 2016 with six sentinel hospitals, and phase I of Kor-GLASS started in January 2017 with eight sentinel hospitals. Previous surveillance data for overestimated AMR due to duplicate isolation of drug-resistant pathogens were corrected and error-free AMR data were compared with those from other countries. One-half (53.2%, 377/708) of Staphylococcus aureus blood strains exhibited resistance to cefoxitin, indicating methicillin-resistant S. aureus. Resistance to ampicillin in Enterococcus faecalis blood strains was rare (0.6%, 1/175), while the resistance rate to penicillin was 26.3% (46/175). Resistance to vancomycin (34.0%, 98/288) and teicoplanin (18.8%, 98/288) was frequently observed in Enterococcus faecium strains. The resistance rate of Escherichia coli strains to cefotaxime was 32.4% (574/1772), and that of Klebsiella pneumoniae strains was 26.1% (181/693). The resistance rates of Pseudomonas aeruginosa strains to imipenem and meropenem were 19.5% (29/149) and 18.1% (27/149), respectively. And 92.1% (187/203) of Acinetobacter baumannii strains were resistant to both imipenem and meropenem. The high incidence of bacteremia caused by major AMR pathogens among hospitalized patients especially in intensive care units emphasized the importance of hospital infection control and the need to improve the crowded hospitalization system in South Korea. The isolation rate of the Salmonella spp. is decreasing, reflecting the current socio-economic status of South Korea. The proportions of bacterial species in the blood strains were similar to those in other Asian countries with similar lifestyles.
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Bacteremia; Global antimicrobial resistance surveillance system; Kor-GLASS; Multi-drug resistance

Mesh:

Substances:

Year:  2019        PMID: 31311694     DOI: 10.1016/j.jiac.2019.06.010

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  15 in total

1.  Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and blaNDM-1 in Korea.

Authors:  Sunghee Han; Jin Seok Kim; Chae-Kyu Hong; Sang-Hun Park; Hee Soon Kim; Jin Kyung Yu; Jungsun Park; Junyoung Kim; Sang-Me Lee; Young-Hee Oh
Journal:  J Antibiot (Tokyo)       Date:  2020-07-14       Impact factor: 2.649

2.  What we can do? The risk factors for multi-drug resistant infection in pediatric intensive care unit (PICU): a case-control study.

Authors:  Zaihua Wang; Zhongfang Xia
Journal:  Ital J Pediatr       Date:  2020-02-07       Impact factor: 2.638

3.  Changes of antibiotic prescribing pattern and its resistance to E. Coli in South Korea: a 12-year retrospective observational study.

Authors:  Geun Woo Lee; Sukhyun Ryu; Juhee Park; Eun Jee Lee; Kwang Jun Lee; Jungyeon Tae; Youngsik Hwang; Dong-Sook Kim
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

4.  Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in Pseudomonas aeruginosa Bacteremia: 12-Year Experience in a Tertiary Hospital in Korea.

Authors:  Jin Suk Kang; Chisook Moon; Seok Jun Mun; Jeong Eun Lee; Soon Ok Lee; Shinwon Lee; Sun Hee Lee
Journal:  J Korean Med Sci       Date:  2021-11-08       Impact factor: 2.153

5.  Biosynthetic Microcin J25 Exerts Strong Antibacterial, Anti-Inflammatory Activities, Low Cytotoxicity Without Increasing Drug-Resistance to Bacteria Target.

Authors:  Haitao Yu; Lijun Shang; Guangxin Yang; Ziqi Dai; Xiangfang Zeng; Shiyan Qiao
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

6.  A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities.

Authors:  Yu Haitao; Chen Yifan; Sun Mingchao; Han Shuaijuan
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

7.  The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections.

Authors:  Seok Jun Mun; Si-Ho Kim; Hyoung-Tae Kim; Chisook Moon; Yu Mi Wi
Journal:  BMC Infect Dis       Date:  2022-04-05       Impact factor: 3.090

8.  Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data.

Authors:  Sollip Kim; Soo Jin Yoo; Jeonghyun Chang
Journal:  Medicina (Kaunas)       Date:  2020-09-28       Impact factor: 2.430

9.  Occurrence, Antimicrobial Resistance and Molecular Diversity of Enterococcus faecium in Processed Pork Meat Products in Korea.

Authors:  Hyun Jung Kim; Minseon Koo
Journal:  Foods       Date:  2020-09-12

10.  Comparing Treatment Outcomes of Ampicillin-Sulbactam, Other β-Lactams, and Vancomycin in Blood Culture-Negative Infective Endocarditis.

Authors:  Se Ju Lee; Jung Ho Kim; Hi Jae Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Nam Kim; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon Sup Yeom; Young Goo Song
Journal:  Antibiotics (Basel)       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.